IQV Technical Analysis

As of date:	12/4/2023
IQV stock price:	216.27
IQV 50 DMA:	197.85
IQV 200 DMA:	205.50
IQV MACD (200-50):	7.65
IQV RSI:	89.62

Extremely Overbought
	89.62
Extremely Oversold

Also see:
IQV Market Cap History
IQV Shares Outstanding History
IQV YTD Return

Quotes delayed 20 minutes

Free IQV Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

Viking Therapeutics Breaks Above 200-Day Moving Average - Bullish for VKTX
48 minutes ago

EBTC Makes Bullish Cross Above Critical Moving Average
48 minutes ago

PLBC Crosses Above Key Moving Average Level
48 minutes ago

RARE Crosses Above Key Moving Average Level
48 minutes ago

Bullish Two Hundred Day Moving Average Cross - SAVA
1 hour, 15 minutes ago

Bullish Two Hundred Day Moving Average Cross - CIVB
1 hour, 17 minutes ago

SASR Crosses Above Key Moving Average Level
1 hour, 18 minutes ago

Bullish Two Hundred Day Moving Average Cross - CMCO
1 hour, 20 minutes ago

Gilead Sciences Breaks Above 200-Day Moving Average - Bullish for GILD
1 hour, 21 minutes ago

CBSH Crosses Above Key Moving Average Level
1 hour, 21 minutes ago

TMP Makes Bullish Cross Above Critical Moving Average
1 hour, 27 minutes ago

Bullish Two Hundred Day Moving Average Cross - PDI
1 hour, 36 minutes ago

Bullish Two Hundred Day Moving Average Cross - RC
1 hour, 36 minutes ago

Bullish Two Hundred Day Moving Average Cross - PDM
1 hour, 36 minutes ago

TRNO Makes Bullish Cross Above Critical Moving Average
1 hour, 41 minutes ago

More Technical Analysis News

IQVIA Holdings is a provider of analytics, technology solutions, and clinical research services to the life sciences industry. Co. is managed through three reportable segments: Technology and Analytics Solutions, which provides information, technology solutions and real-world insights and services to its life science clients; Research and Development Solutions, which primarily serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services; and Contract Sales and Medical Solutions, which provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the healthcare market.

When researching a stock like IQVIA Holdings, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from IQV Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for IQV stock — the real life supply and demand for the stock over time — and examines that data in different ways.

10 Most Oversold S&P 500 Stocks

10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying

10 ETFs With Most Upside To Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active S&P Call & Put Options

Video: Technical Analysis

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

IQVIA Holdings (IQV) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

ISRG Technical Analysis
JNJ Technical Analysis
LH Technical Analysis
LLY Technical Analysis
MCK Technical Analysis
MDT Technical Analysis
MMM Technical Analysis
MOH Technical Analysis
MRK Technical Analysis
MRNA Technical Analysis
More Healthcare companies »

Join TechnicalAnalysisChannel.com
Create a FREE account to continue
Already have an account? LOG IN

Full Disclaimer & Terms of Use and Privacy Policy. Important: If you are in Canada or the European Union, you must click here for alternate registration page.

✓

Immediate access to our IQV Technical Analysis page as well as our full coverage universe of stocks

✓

Complimentary report on monthly dividend paying stocks

✓

Daily market updates from our Contrarian Outlook team

✓

Join FREE with just your email address

Welcome back!

TechnicalAnalysisChannel.com and parent company BNK Invest, Inc. value our relationship with you and would like to continue providing accurate and tailored communications to fit your investing needs. To receive our publications and other relevant communications, Canada's anti-spam legislation (''CASL'') and the European Union's General Data Protection Regulation (''GPDR'') requires us to obtain your express consent. Please provide your consent to continue. In any email we send, you will be given the option to withdraw your consent or unsubscribe from any or all of our newsletters or publications at any time.

IQV Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2023, All Rights Reserved